ArrowHead Pharma
ARWR85.4000.15% ( -0.130 )
Q2 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: ArrowHead Pharma(ARWR) predict that the Revenue is 73.74 M (-86.41%), Beat estimate;the EBIT is -141.26 M (-137.1%), Beat estimate;the EPS is -0.93 (-133.8%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.07B86.41%
0.07B86.79%
+0.00B0.38%
EBITExceed expectations
-0.14B137.06%
-0.15B140.45%
+0.01B3.39%
EPSExceed expectations
-0.93133.82%
-1.115140.55%
+0.18506.73%
Upcoming earnings report - FY2026 Q3 Earning Release
Available dateAug 4, 2026
Estimate Revenue44.04 M
Estimate EBIT-175.82 M
Estimate EPS-1.2787
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf